Methylenedioxyamphetamine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Lua error in package.lua at line 80: module 'strict' not found.

Tenamfetamine (INN)
MDA-2D-skeletal.svg
MDA molecule ball.png
Systematic (IUPAC) name
(R) 1-(benzo[1,3]dioxol-5-yl)propan-2-amine
Clinical data
Legal status
Routes of
administration
Oral, Sublingual, Insufflation
Pharmacokinetic data
Metabolism Hepatic, CYP extensively involved
Excretion Renal
Identifiers
CAS Number 4764-17-4 YesY
ATC code None
PubChem CID: 1614
DrugBank DB01509 YesY
ChemSpider 1555 YesY
UNII XJZ28FJ27W YesY
ChEMBL CHEMBL6731 YesY
Chemical data
Formula C10H13NO2
Molecular mass 179.22 g/mol
  • NC(C)CC1=CC2=C(C=C1)OCO2
  • InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3 YesY
  • Key:NGBBVGZWCFBOGO-UHFFFAOYSA-N YesY
  (verify)

Methylenedioxyamphetamine, also known as 3,4-methylenedioxy-amphetamine, MDA, tenamfetamine (INN), or colloquially as "Sally", "Sass", or "Sass-a-frass", is a psychoactive drug of the substituted methylenedioxyphenethylamine and substituted amphetamine classes of drugs that is consumed primarily for its entactogenic, psychedelic, and psychostimulant effects. Pharmacologically, MDA acts as a serotonin-norepinephrine-dopamine releasing agent and reuptake inhibitor. Possession of MDA is illegal in most countries. Some limited exceptions exist for scientific and medical research. The recreational use of MDA predates its more widely used analog MDMA (ecstasy).

Use

Medical

MDA currently has no accepted medical use.

Recreational

Although illegal, MDA is bought, sold, and used as a recreational 'love drug', due to its enhancement of empathy.[1] A recreational dose of MDA is commonly between 100 and 160 mg.[2]

Effects

Lua error in package.lua at line 80: module 'strict' not found. While MDA is generally similar to MDMA, users report that MDA has more stimulant and psychedelic qualities and less intense entactogenic effects than MDMA. MDA is also considered less predictable than MDMA, with effects varying greatly from person to person. MDA is best known for its enhancement of the experiences of dancing and sex.[medical citation needed]

Overdose

Symptoms of acute toxicity may include agitation, sweating, increased blood pressure and heart rate, dramatic increase in body temperature, convulsions, and death. Death is usually caused by cardiac effects and subsequent hemorrhaging in the brain (stroke).[3][medical citation needed]

Pharmacology

Pharmacodynamics

MDA is a substrate of the serotonin, norepinephrine, and dopamine transporters, as well as a TAAR1 agonist,[4][5] and for that reason, acts as a reuptake inhibitor and releasing agent of serotonin, norepinephrine, and dopamine (or as an SNDRA).[6] It is also an agonist of the 5-HT2A,[7] 5-HT2B,[8] and 5-HT2C receptors,[9] and shows affinity for the α2A-, α2B-, α2C-adrenergic receptors and 5-HT1A and 5-HT7 receptors.[10]

The effect on serotonin may explain the similar euphoric and empathogenic effects of the two compounds MDMA and MDA. However, (S)-MDA has a higher efficacy in stimulating the 5-HT2A receptor than (R)-MDMA; thus MDA tends to cause more psychedelic-like effects, such as visual hallucinations. MDMA can also produce psychedelic-like visual effects, though these are generally less pronounced than those of MDA, or require a heavier dose to become apparent.[medical citation needed]

Pharmacokinetics

The "S" optical isomer of MDA is more potent than the "R" optical isomer as a psychostimulant, possessing greater affinity for the three monoamine transporter proteins (SERT, NET and DAT). The duration of the drug has been reported as about 6 to 8 hours.[2]

Physical and chemical properties

Synthesis

MDA is typically synthesized from essential oils such as safrole or piperonal. Common approaches from these precursors include:

Synthesis of MDA and related analogs from safrole

Detection in body fluids

MDA may be quantitated in blood, plasma or urine to monitor for use, confirm a diagnosis of poisoning or assist in the forensic investigation of a traffic or other criminal violation or a sudden death. Some drug abuse screening programs rely on hair, saliva, or sweat as specimens. Most commercial amphetamine immunoassay screening tests cross-react significantly with MDA and major metabolites of MDMA, but chromatographic techniques can easily distinguish and separately measure each of these substances. The concentrations of MDA in the blood or urine of a person who has taken only MDMA are, in general, less than 10% those of the parent drug.[19][20][21]

History

MDA was first synthesized by C. Mannich and W. Jacobsohn in 1910.[14] It was first ingested in July 1930 by Gordon Alles who later licensed the drug to Smith, Kline & French.[22] MDA was first used in animal tests in 1939, and human trials began in 1941 in the exploration of possible therapies for Parkinson's disease. From 1949 to 1957, more than 500 human subjects were given MDA in an investigation of its potential use as an antidepressant and/or anorectic by Smith, Kline & French. The United States Army also experimented with the drug, code named EA-1298, while working to develop a truth drug or incapacitating agent. Harold Blauer[23] died in January 1953 after being intravenously injected with 450 mg of the drug. MDA was patented as a cough suppressant by H. D. Brown in 1958, as an ataractic by Smith, Kline & French in 1960, and as an anorectic under the trade name "Amphedoxamine" in 1961. MDA began to appear on the recreational drug scene around 1963 to 1964. It was then inexpensive and readily available as a research chemical from several scientific supply houses. Several researchers, including Claudio Naranjo and Richard Yensen, have explored MDA in the field of psychotherapy.[24][25]

Legal Status

Australia

MDA is schedule 9 prohibited substance under the Poisons Standards.[26] A schedule 9 substance is listed as a "Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities."[26]

Research

In 2010, Matthew Baggott and colleagues studied the ability of MDA to invoke mystical experiences and alter vision in healthy volunteers.[27]

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. 2.0 2.1 Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson, JE. Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans. doi:10.1371/journal.pone.0014074
  3. Diaz, Jaime. How Drugs Influence Behavior. Englewood Cliffs: Prentice Hall, 1996.
  4. Lua error in package.lua at line 80: module 'strict' not found.
  5. Lua error in package.lua at line 80: module 'strict' not found.
  6. Lua error in package.lua at line 80: module 'strict' not found.
  7. Lua error in package.lua at line 80: module 'strict' not found.
  8. Lua error in package.lua at line 80: module 'strict' not found.
  9. Lua error in package.lua at line 80: module 'strict' not found.
  10. Lua error in package.lua at line 80: module 'strict' not found.
  11. Lua error in package.lua at line 80: module 'strict' not found.
  12. 12.0 12.1 12.2 Lua error in package.lua at line 80: module 'strict' not found.
  13. Lua error in package.lua at line 80: module 'strict' not found.
  14. 14.0 14.1 Lua error in package.lua at line 80: module 'strict' not found.
  15. Lua error in package.lua at line 80: module 'strict' not found.
  16. Lua error in package.lua at line 80: module 'strict' not found.
  17. Lua error in package.lua at line 80: module 'strict' not found.
  18. Lua error in package.lua at line 80: module 'strict' not found.
  19. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther. Drug Monit. 30: 320–332, 2008.
  20. Lua error in package.lua at line 80: module 'strict' not found.
  21. R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 9th edition, Biomedical Publications, Seal Beach, California, 2011, pp. 1078–1080.
  22. The First MDA trip and the measurement of ‘mystical experience’ after MDA, LSD, and Psilocybin http://psychedelicresearch.org/?p=45
  23. The History Channel documented details of his death here http://www.youtube.com/watch?v=ySw-0uY4CUA See minute 2:38 onward.
  24. Lua error in package.lua at line 80: module 'strict' not found.
  25. Lua error in package.lua at line 80: module 'strict' not found.
  26. 26.0 26.1 Poisons Standard (October 2015) https://www.comlaw.gov.au/Details/F2015L01534/Html/Text#_Toc420496379
  27. Lua error in package.lua at line 80: module 'strict' not found.

External links